| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.03▼ | 1.05▼ | 1.07▼ | 1.11▼ | 1.04▼ |
| MA10 | 1.07▼ | 1.08▼ | 1.05▼ | 1.19▼ | 1.08▼ |
| MA20 | 1.09▼ | 1.05▼ | 1.07▼ | 1.05▼ | 1.43▼ |
| MA50 | 1.06▼ | 1.13▼ | 1.18▼ | 1.07▼ | 3.04▼ |
| MA100 | 1.11▼ | 1.18▼ | 1.09▼ | 1.49▼ | N/A |
| MA200 | 1.20▼ | 1.04▼ | 1.03▼ | 2.23▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.014▼ | 0.000▼ | 0.002▲ | 0.001▲ | 0.138▲ |
| RSI | 34.515▼ | 37.036▼ | 38.323▼ | 46.039▼ | 38.061▼ |
| STOCH | 25.694 | 42.743 | 68.577 | 34.753 | 30.428 |
| WILL %R | -100.000▼ | -66.079 | -67.850 | -70.833 | -79.198▼ |
| CCI | -123.142▼ | -61.081 | -75.972 | -42.850 | -42.789 |
|
Tuesday, April 29, 2025 06:20 AM
FibroBiologics, Inc., a clinical-stage biotechnology company with a focus on developing therapeutics for chronic diseases, has announced that research scientist Simon Gebremeskel will present a ...
|
|
Tuesday, April 29, 2025 06:15 AM
FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
|
|
Tuesday, April 29, 2025 02:14 AM
Fibrobiologics, Inc. HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 1.13 | 1.13 | 1.00 | 1.02 | 99,900 |
| 30/04/25 | 1.01 | 1.13 | 0.948 | 1.12 | 220,300 |
| 29/04/25 | 1.14 | 1.14 | 1.02 | 1.04 | 235,445 |
| 28/04/25 | 1.20 | 1.269 | 1.08 | 1.135 | 162,300 |
| 25/04/25 | 1.29 | 1.3266 | 1.1609 | 1.22 | 173,117 |
| 24/04/25 | 1.31 | 1.31 | 1.212 | 1.29 | 205,300 |
| 23/04/25 | 1.33 | 1.33 | 1.23 | 1.29 | 230,300 |
| 22/04/25 | 1.44 | 1.53 | 1.20 | 1.26 | 418,500 |
| 21/04/25 | 1.22 | 1.44 | 1.15 | 1.38 | 499,400 |
| 17/04/25 | 1.08 | 1.23 | 1.00 | 1.19 | 352,372 |
|
|
||||
|
|
||||
|
|